SBIR/STTR Research Award
Osteoporosis Screen for Praja 1 E3 Ligase Inhibitors
Award amount
$149,800Program and phase
SBIR · Phase IAward year
2004Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- PROGENRA INC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Z3JKMHXHFHJ6
- Solicitation number
- PHS2004-2
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): 0steoporosis represents a major challenge to the maintenance of health and quality of life in an aging population. Among the most promising and least exploited therapeutic interventions are those treatments designed to
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Ubiquitin pathway modulators as novel antituberculosis drugs
- Ubiquitin pathway modulators for treating pancreatitis
- Parkin activators for cardioprotective therapies
- Development of ITCH-activating IRAK4 degraders as dual-targeting drug candidates for the treatment of rheumatoid arthritis
- Novel TXNIP degraders for treating diabetes
Research funding history
53 SBIR/STTR records share this UEI (2003–2025). Reported award amounts total $22,552,905. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services